These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4055040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
    Iannini PB.
    Infection; 1985; 13 Suppl 1():S3-6. PubMed ID: 4055052
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.
    Helwig HF.
    Infection; 1985; 13 Suppl 1():S62-7. PubMed ID: 4055057
    [Abstract] [Full Text] [Related]

  • 4. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
    Fujii R.
    Infection; 1985; 13 Suppl 1():S9-13. PubMed ID: 4055062
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
    Zhu M, Hu Q, Mai J, Lin Z.
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
    [Abstract] [Full Text] [Related]

  • 9. The use of cefotaxime in the treatment of gram-positive pneumonias.
    Jenkinson SG.
    Infection; 1985 Jan; 13 Suppl 1():S14-7. PubMed ID: 4055045
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of cefotaxime in severe infections in newborn infants].
    Peskine F, Astruc J, Rodiére M, Echenne B, Brunel D.
    Pathol Biol (Paris); 1984 Dec; 32(10):1040-2. PubMed ID: 6096793
    [Abstract] [Full Text] [Related]

  • 14. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
    LeFrock J, Mader J, Smith B, Carr B.
    Infection; 1985 Dec; 13 Suppl 1():S50-5. PubMed ID: 4055056
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.
    Schleupner CJ.
    Infection; 1985 Dec; 13 Suppl 1():S28-33. PubMed ID: 4055051
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The use of cefotaxime against infections (author's transl)].
    Lepeu G, Bertrand A, Armengaud M, Aubertin J.
    Nouv Presse Med; 1981 Feb 26; 10(8):594-7. PubMed ID: 6259600
    [Abstract] [Full Text] [Related]

  • 18. Clinical efficacy of cefotaxime in serious infections.
    Karakusis PH, Feczko JM, Goodman LJ, Hanlon DM, Harris AA, Levin S, Trenholme GM.
    Antimicrob Agents Chemother; 1982 Jan 26; 21(1):119-24. PubMed ID: 6282202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Workshop on five years of clinical experience with cefotaxime (with special reference to gram-positive infections). February 21 and 22, 1985, West Berlin.
    Infection; 1985 Jan 26; 13 Suppl 1():S1-162. PubMed ID: 3902651
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.